TARGETING THE B-CELL RECEPTOR PATHWAY: THE CLINICAL SIGNIFICANCE IN CLL

被引：0
|
作者：
Kotsianidis, Ioannis [1 ,2 ]
机构：
[1] Democritus Univ Thrace, Hematol, Alexandroupolis, Greece
[2] Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece
来源：
LEUKEMIA RESEARCH | 2016年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-29
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] The clinical significance of T-cell receptor gene rearrangement in B-CELL chronic lymphocytic leukaemia
    Catherwood, M. A.
    Galligan, L.
    Gonzalez, D.
    Morris, T. C. M.
    Alexander, H. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 472 - 473
  • [22] Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of B-Cell Receptor Pathway Signaling
    Sharman, Jeff P.
    Shustov, Andrei R.
    Smith, Mitchell R.
    Boyd, Thomas E.
    Hagenstad, Christopher
    Kolibaba, Kathryn S.
    Abella, Steve
    He, Jing
    Eng, Clarence
    Hu, Jing
    Reddy, Anita
    Mitra, Siddhartha
    Yasenchak, Christopher A.
    Awan, Farrukh T.
    BLOOD, 2015, 126 (23)
  • [23] Common recognition principles of B-cell receptor immunoglobulins in CLL and autoimmune disorders
    Binder, M.
    Seismann, H.
    Wehr, C.
    Ummanni, R.
    Balabanov, S.
    Trepel, M.
    ONKOLOGIE, 2011, 34 : 195 - 195
  • [24] Induction of Apoptosis in CLL by Peptides Binding the B-Cell Antigen Receptor in Vitro
    Woelfle, Manuela
    Seiler, Till
    Catera, Rosa
    Dohner, Hartmut
    Stilgenbauer, Stephan
    Allen, Steven L.
    Rai, Kanti
    Chu, Charles
    Chiorazzi, Nicholas
    BLOOD, 2008, 112 (11) : 1080 - 1081
  • [25] Clinical significance of homozygous D13S319 deletion in B-cell chronic lymphocytic leukemia (B-CLL).
    Fink, S
    Geyer, S
    Shanafelt, T
    Smoley, S
    Paternoster, S
    Giordano, K
    Tschumper, R
    Jelinkek, D
    Bone, N
    Kabat, B
    Call, T
    Phyliky, R
    Kay, N
    Dewald, G
    BLOOD, 2004, 104 (11) : 766A - 766A
  • [26] Clinical significance of ZAP-70 protein performed by flow cytometry in B-cell chronic lymphocytic leukemia (B-CLL)
    Del Poeta, G
    Del Principe, MI
    Piccioni, D
    Suppo, G
    Buccisano, F
    Marini, R
    Bruno, A
    Amadori, S
    CYTOMETRY PART A, 2004, 59A (01): : 38 - 38
  • [27] The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance
    Casola, Stefano
    Perucho, Laura
    Tripodo, Claudio
    Sindaco, Paola
    Ponzoni, Maurilio
    Facchetti, Fabio
    IMMUNOLOGICAL REVIEWS, 2019, 288 (01) : 198 - 213
  • [28] B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway
    Clark, MR
    Massenburg, D
    Siemasko, K
    Hou, P
    Zhang, M
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (03) : 382 - 387
  • [29] Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells
    Shorer Arbel, Yamit
    Katz, Ben-Zion
    Gabizon, Ronen
    Shraga, Amit
    Bronstein, Yotam
    Kamdjou, Talia
    Globerson Levin, Anat
    Perry, Chava
    Avivi, Irit
    London, Nir
    Herishanu, Yair
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Axl Regulates Fibroblast Growth Factor Receptor Signaling in B-Cell Chronic Lymphocytic Leukemia: Dual Targeting in CLL Therapy
    Sinha, Sutapa
    Boysen, Justin
    Secreto, Charla
    Warner, Steven L.
    Kay, Neil E.
    Ghosh, Asish K.
    BLOOD, 2014, 124 (21)
12345